Optus Pharmaceutical Co Ltd
KOSDAQ:131030
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
O
|
Optus Pharmaceutical Co Ltd
KOSDAQ:131030
|
KR |
|
N
|
Norsk Hydro ASA
DUS:NOH1
|
NO |
Intrinsic Value
The intrinsic value of Optus Pharmaceutical Co Ltd (131030) under the Base Case is 6 871.83 KRW per share. Compared with the current market price of 5 950 KRW, the stock appears Undervalued by 13% .
The intrinsic value is calculated using valuation multiples.
Do our valuations actually work? See backtest results .
Cheap or expensive for this stock?
This block shows whether today’s valuation is cheap or expensive compared with the stock’s own history, and what happened after similar valuations in the past.
We compare the gap between the stock’s price and our estimated value over time.
- Undervalued can still be historically expensive. The stock may trade below our estimated value, but usually offer an even bigger discount.
- Overvalued can still be historically cheap. The stock may trade above our estimated value, but usually carry an even higher premium.
Market expectations can differ from our model, which may not fully capture everything affecting the price. That is why some stocks regularly trade above our estimated value and others below it.
The scale and chart show how today’s valuation compares with the past. The cards summarize past returns and waiting times until the stock stopped being cheap or expensive. This can happen because the price changed, our estimated value changed, or both.
Only completed periods are included. These are past results, not forecasts. The usual historical range does not necessarily mean fair value.
Fundamental Analysis
What Optus Pharmaceutical Does
Optus Pharmaceutical Co Ltd is a South Korean drug maker that develops, manufactures, and sells pharmaceutical products. Its business is centered on finished medicines rather than drug research for licensing, so it makes money by producing and selling products that doctors, hospitals, pharmacies, and other distributors buy for patient care.
- Headquarters
- Korea KR
- Employees
- 171
- IPO date
- Dec 3, 2010
Revenue & Expenses Breakdown
Optus Pharmaceutical Co Ltd
Earnings Waterfall
Optus Pharmaceutical Co Ltd
The intrinsic value for Optus Pharmaceutical Co Ltd (131030) under the Base Case is 6 871.83 KRW.
Compared with the current market price of 5 950 KRW, the stock appears Undervalued by 13% .